• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014 - Product Image

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014

  • Published: March 2014
  • Region: Global
  • 183 pages
  • GlobalData

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014

Summary

Our clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014" provides data on the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of READ MORE >

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Feb 12, 2014: BioLineRx Announces Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia
Oct 18, 2013: ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia
Sep 04, 2013: ARIAD Reaches 50 Percent Patient Enrollment in Phase 3 EPIC Trial of Iclusig
Jun 02, 2013: Ariad Pharma Announces Long-term Durability-of-response Data On Ponatinib From Ongoing Phase I Study
Jun 01, 2013: Ariad Pharma Reports Analysis Of Cardiovascular Risk Profile Of Leukemia Patients From Pivotal Phase II PACE Trial Of Iclusig
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Ariad Pharmaceuticals, Inc.
Clinical Trial Overview of Ariad Pharmaceuticals, Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Teva Pharmaceutical Industries Limited
Clinical Trial Overview of Teva Pharmaceutical Industries Limited
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
Clinical Trial Overview of Gruppo Italiano Malattie EMatologiche dell'Adulto
Australasian Leukaemia and Lymphoma Group
Clinical Trial Overview of Australasian Leukaemia and Lymphoma Group
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, North America, Top Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014-
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, G7 Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014-
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, E7 Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Phase 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Trial Status, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, by End Point Status, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Suspended Clinical Trials, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Withdrawn Clinical Trials, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Terminated Clinical Trials, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ariad Pharmaceuticals, Inc., 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Gruppo Italiano Malattie EMatologiche dell'Adulto, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials Market, Global, Clinical Trials by Australasian Leukaemia and Lymphoma Group, 2014-

List of Figures
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, North America, Top Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014-
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, G7 Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014-
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, E7 Countries (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Phase (%), 2014-
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Trial Status, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, by End Point Status, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos